Home > Market > Market Stats > Indoco remedies
  1. S&P BSE SENSEX
    52,727.98 462.26 (0.88%)
  1. NIFTY 50 D
    Delayed by 15 mins

    15,699.25 142.6 (0.92%)
  1. NIFTY BANK D
    Delayed by 15 mins

    33,627.45 492.45 (1.49%)
  1. S&P BSE MIDCAP
    21,803.16 328.34 (1.53%)

INRM.BO Indoco Remedies - Share price

367.35 0.85 (0.23%) 24 JUN 2022 09:58:00
366.9 -1.45 (-0.39%) 24 Jun 2022 10:10:19
Add Stock to Portfolio / Watchlist on mint Genie + Add Stock
  1. Open price371.25
  2. Prev close366.5
  3. Day high371.35
  4. Day low364.0
  5. 52 week high529.7
  6. 52 week low321.05
  7. Bid quantity0.0
  8. Volume495
  1. Open price370.2
  2. Prev close368.35
  3. Day high372
  4. Day low362.05
  5. 52 week high530.25
  6. 52 week low322.7
  7. Bid quantity
  8. Volume40473

Indoco Remedies Financials

Standalone
Revenue
1,241.53
Total Revenue
1,241.53
Costof Revenue Total
407.02
Gross Profit
834.51
Selling/ General/ Admin Expenses Total
514.68
Research Development
597.04
Depreciation/ Amortization
73.13
Unusual Expense( Income)
0
Other Operating Expenses Total
35.59
Total Operating Expense
1,090.12
Operating Income
151.41
Interest Inc( Exp) Net- Non- Op Total
-204.09
Gain( Loss)on Saleof Assets
-2.43
Other Net
1.24
Net Income Before Taxes
132
Provisionfor Income Taxes
38.95
Net Income After Taxes
93.05
Minority Interest
0
Net Income Before Extra Items
93.05
Net Income
93.05
Income Availableto Com Excl Extra Ord
93.05
Income Availableto Com Incl Extra Ord
93.05
Diluted Net Income
93.05
Diluted Weighted Average Shares
9.22
Diluted EPS Excluding Extra Ord Items
10.1
DPS- Common Stock Primary Issue
1.5
Diluted Normalized EPS
10.12
COMPANY INFORMATION
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company's geographical segments include India and Outside India. The Company has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.
Industry Biotechnology & Drugs
ISIN INE873D01024
BSE code 532612
NSE code INDOCO
Executive Chairman of the BoardSuresh   Kare
Chief Executive Officer, Managing Director, Executive DirectorAditi   Panandikar
Chief Financial OfficerPramod   Ghorpade
Compliance Officer, Company SecretaryJayshankar   Menon
Joint Managing Director, Executive DirectorSundeep   Bambolkar
NEWS - Indoco remedies
View More News
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout